From The Associated Press

More Leeway for States to Expand Inpatient Mental Health

November 13, 2018

The Trump administration Tuesday allowed states to provide more inpatient treatment for people with serious mental illness by tapping Medicaid, a potentially far-reaching move to address issues from homelessness to violence.

The Trump administration Tuesday allowed states to provide more inpatient treatment for people with serious mental illness by tapping Medicaid, a potentially far-reaching move to address issues from homelessness to violence.

Health and Human Services Secretary Alex Azar made the announcement Tuesday in a speech to state Medicaid directors, a group that represents Republican and Democratic officials from around the country who are confronting common, deeply-rooted social problems…

Read the full ABC News/The Associated Press article

Share on Facebook Share on Twitter Employers jump into providing care as health costs rise

September 30, 2018

KOKOMO, Indiana — Autoworkers in this blue-collar, central Indiana city have an eager helper waiting to pick up the bill at their next doctor visit.

KOKOMO, Indiana — Autoworkers in this blue-collar, central Indiana city have an eager helper waiting to pick up the bill at their next doctor visit.

Fiat Chrysler is offering free health care for most of its employees and their families — about 22,000 people — through a clinic the carmaker opened this summer near one of five factories it operates in the area. The company pays for basic care like doctor visits and consults with a dietitian and even an exercise physiologist. Workers don’t pay a cent, not even a co-pay…

Read the full The Associated Press article

AP investigation: Drug prices going up despite Trump promise

September 24, 2018

NEW YORK (AP) — President Donald Trump made reducing drug prices a key promise during his election campaign, repeatedly accusing drugmakers of “getting away with murder.” At the end of May, he promised that drug companies would be announcing “massive” voluntary drug price cuts within two weeks.

NEW YORK (AP) — President Donald Trump made reducing drug prices a key promise during his election campaign, repeatedly accusing drugmakers of “getting away with murder.” At the end of May, he promised that drug companies would be announcing “massive” voluntary drug price cuts within two weeks.

That hasn’t happened, and an Associated Press analysis of brand-name prescription drug prices shows it’s been business as usual for drugmakers, with far more price hikes than cuts. The number of increases slowed somewhat and were not quite as steep as in past years, the AP found…

Read the full The Associated Press article

Report: Trump Administration Needs to Step up on ‘Obamacare’

August 23, 2018

WASHINGTON (AP) — A congressional watchdog said the Trump administration needs to step up its management of sign-up seasons for former President Barack Obama’s health care law after mixed results last year in the throes of a failed GOP effort to repeal it.

WASHINGTON (AP) — A congressional watchdog said the Trump administration needs to step up its management of sign-up seasons for former President Barack Obama’s health care law after mixed results last year in the throes of a failed GOP effort to repeal it.

The report due out Thursday from the Government Accountability Office is likely to add to Democrats’ election-year narrative that the administration actively undermined “Obamacare” without regard for the consequences to consumers.

The nonpartisan Government Accountability Office was more nuanced. On one hand, it found problems with consumer counseling and advertising and recommended such basic fixes as setting enrollment targets. But it also credited administration actions that did help people enroll, such as a more reliable HealthCare.gov website and reduced call center wait times.

Read the full The Associated Press article

Hopes rise again for a drug to slow Alzheimer’s disease

July 25, 2018

Hopes are rising again for a drug to alter the course of Alzheimer’s disease after decades of failures. An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study, and it removed much of the sticky plaque gumming up their brains, the drug’s makers said Wednesday.

Hopes are rising again for a drug to alter the course of Alzheimer’s disease after decades of failures. An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study, and it removed much of the sticky plaque gumming up their brains, the drug’s makers said Wednesday.

The results have been highly anticipated and have sent the stock of the two companies involved soaring in recent weeks.

The drug from Eisai and Biogen did not meet its main goal in a study of 856 participants, so overall, it was considered a flop. But company officials said that 161 people who got the highest dose every two weeks for 18 months did significantly better than 245 people who were given a dummy treatment….

Read the full The Associated Press article